Xulane 150-35 MCG/day patch 3S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Y25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,127
Award facts
- Contract value 100% obligated
- $12,126.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,126.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 3-count packages of Xulane 150-35 mcg/day transdermal patches. This is a non-set-aside award issued on January 16, 2026, with an ultimate completion date of January 20, 2026. The delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999 through December 2026), which serves as a global pharmaceutical support vehicle for supplying medications and medical supplies to military healthcare systems worldwide. The awardee's parent company is Cencora, Inc., which operates under the AmerisourceBergen doing-business-as name and holds the primary IDC with DLA.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for the Department of Defense and other government healthcare systems. The company has an extensive portfolio of federal contract awards covering diverse therapeutic domains including diabetes medications, neurological treatments, and pain management pharmaceuticals. As a critical vendor in the federal supply chain, AmerisourceBergen competes on a full and open basis for contract opportunities and demonstrates consistent capability in fulfilling time-sensitive pharmaceutical delivery requirements for military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F5Y25?
SPE2DR26F5Y25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F5Y25 worth?
The government has obligated $12,127 on SPE2DR26F5Y25.
Is contract SPE2DR26F5Y25 an order under another contract?
Yes. SPE2DR26F5Y25 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Y25 competed?
The extent of competition for SPE2DR26F5Y25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award